A detailed history of California State Teachers Retirement System transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 15,073 shares of AKBA stock, worth $28,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,073
Previous 15,073 -0.0%
Holding current value
$28,638
Previous $15,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.86 - $1.63 $12,962 - $24,568
15,073 New
15,073 $15,000
Q2 2022

Aug 15, 2022

SELL
$0.32 - $0.67 $69,081 - $144,640
-215,881 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.72 - $2.93 $14,057 - $57,205
-19,524 Reduced 8.29%
215,881 $155,000
Q4 2021

Feb 15, 2022

BUY
$2.26 - $3.34 $43,346 - $64,061
19,180 Added 8.87%
235,405 $532,000
Q3 2021

Nov 15, 2021

SELL
$2.35 - $3.88 $9,353 - $15,442
-3,980 Reduced 1.81%
216,225 $623,000
Q2 2021

Aug 16, 2021

BUY
$2.83 - $4.2 $12,013 - $17,829
4,245 Added 1.97%
220,205 $835,000
Q1 2021

May 18, 2021

SELL
$2.92 - $5.06 $2,435 - $4,220
-834 Reduced 0.38%
215,960 $731,000
Q3 2020

Nov 17, 2020

BUY
$2.39 - $13.08 $49,057 - $268,480
20,526 Added 10.46%
216,794 $544,000
Q2 2020

Aug 17, 2020

BUY
$6.67 - $13.58 $119,793 - $243,896
17,960 Added 10.07%
196,268 $2.67 Million
Q1 2020

May 13, 2020

SELL
$4.1 - $10.24 $8,249 - $20,602
-2,012 Reduced 1.12%
178,308 $1.35 Million
Q4 2019

Feb 14, 2020

SELL
$3.16 - $6.73 $11,511 - $24,517
-3,643 Reduced 1.98%
180,320 $1.14 Million
Q3 2019

Nov 15, 2019

BUY
$3.55 - $5.4 $7,802 - $11,869
2,198 Added 1.21%
183,963 $721,000
Q2 2019

Aug 14, 2019

BUY
$4.1 - $8.05 $206,615 - $405,671
50,394 Added 38.36%
181,765 $880,000
Q1 2019

May 09, 2019

SELL
$5.41 - $8.73 $16,305 - $26,312
-3,014 Reduced 2.24%
131,371 $1.08 Million
Q4 2018

Feb 13, 2019

BUY
$5.39 - $9.15 $305,683 - $518,923
56,713 Added 73.02%
134,385 $743,000
Q3 2018

Nov 14, 2018

BUY
$7.44 - $10.65 $3,794 - $5,431
510 Added 0.66%
77,672 $686,000
Q2 2018

Aug 14, 2018

BUY
$9.15 - $11.34 $83,493 - $103,477
9,125 Added 13.41%
77,162 $770,000
Q1 2018

May 15, 2018

SELL
$9.53 - $15.68 $24,015 - $39,513
-2,520 Reduced 3.57%
68,037 $648,000
Q4 2017

Feb 14, 2018

SELL
$14.24 - $19.59 $14,652 - $20,158
-1,029 Reduced 1.44%
70,557 $1.05 Million
Q3 2017

Nov 13, 2017

BUY
$13.06 - $19.67 $934,913 - $1.41 Million
71,586
71,586 $1.41 Million

Others Institutions Holding AKBA

About Akebia Therapeutics, Inc.


  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $349M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.